-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Inhibitor Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2012 to 2023.
- Inhibitor Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 172M shares, a 0.21% increase year-over-year.
- Inhibitor Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 172M shares, a 53% decline from 2022.
- Inhibitor Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 366M shares, a 2.68% decline from 2021.
- Inhibitor Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 376M shares.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)